The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 6, Pages 3249
Publisher
MDPI AG
Online
2022-03-21
DOI
10.3390/ijms23063249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EphA2 promotes tumorigenicity of cervical cancer by up‐regulating CDK6
- (2021) Changhao Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
- (2021) Joonas Jukonen et al. Scientific Reports
- Molecular Biology of Ovarian Cancer: From Mechanisms of Intraperitoneal Metastasis to Therapeutic Opportunities
- (2021) Krzysztof Książek Cancers
- The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread
- (2021) Alexandros Pergaris et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing
- (2021) Robert Hudecek et al. Frontiers in Immunology
- Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
- (2020) Lidia Moyano‐Galceran et al. EMBO Molecular Medicine
- Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions
- (2020) Chiyi Xiong et al. Scientific Reports
- A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction
- (2020) Menghuang Zhao et al. International Journal of Genomics
- First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors
- (2019) Ignacio Garrido-Laguna et al. INTERNATIONAL JOURNAL OF CANCER
- Eph receptor signalling: from catalytic to non-catalytic functions
- (2019) Lung-Yu Liang et al. ONCOGENE
- Activated EphA2 Processing by MT1-MMP Is Involved in Malignant Transformation of Ovarian TumoursIn Vivo
- (2018) YOKO TAKAHASHI et al. ANTICANCER RESEARCH
- Decreased Eph receptor‑A1 expression is related to grade in ovarian serous carcinoma
- (2018) Yunfeng Jin et al. Molecular Medicine Reports
- miR-204 Regulates Cell Proliferation and Invasion by Targeting EphB2 in Human Cervical Cancer
- (2018) Shanhong Duan et al. ONCOLOGY RESEARCH
- The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer – A Retrospective Study
- (2017) Veronika Seebacher et al. PLoS One
- Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma
- (2017) Ling-Dan Dong et al. Oncology Letters
- Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2
- (2017) Masaki Takasugi et al. Nature Communications
- Eph Receptor Tyrosine Kinases in Tumor Immunity
- (2016) Eileen Shiuan et al. CANCER RESEARCH
- EphA2 is a functional receptor for the growth factor progranulin
- (2016) Thomas Neill et al. JOURNAL OF CELL BIOLOGY
- Mechanisms of ephrin–Eph signalling in development, physiology and disease
- (2016) Artur Kania et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma
- (2016) Xiao Chen et al. Journal of Ovarian Research
- EphA8 is a prognostic marker for epithelial ovarian cancer
- (2016) Xiaoqin Liu et al. Oncotarget
- Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
- (2015) M. Damelin et al. CLINICAL CANCER RESEARCH
- A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohort
- (2015) Theresa L. Werner et al. INVESTIGATIONAL NEW DRUGS
- Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival
- (2015) Yun Gu et al. JOURNAL OF CLINICAL PATHOLOGY
- Potential molecular signatures in epithelial ovarian cancer by genome wide expression profiling
- (2014) Yin-Ling Wong et al. Asia-Pacific Journal of Clinical Oncology
- Genomic Characterization of Gene Copy-Number Aberrations in Endometrial Carcinoma Cell Lines Derived from Endometrioid-Type Endometrial Adenocarcinoma
- (2014) Yingmei Wang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Epigenetics and cervical cancer: from pathogenesis to therapy
- (2014) Jinchuan Fang et al. TUMOR BIOLOGY
- Structures of an Eph receptor tyrosine kinase and its potential activation mechanism
- (2014) Qiang Wei et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines
- (2014) Brittany Anne Davidson et al. Frontiers in Oncology
- After repeated division, bone marrow stromal cells express inhibitory factors with osteogenic capabilities, and EphA5 is a primary candidate
- (2013) Tsuyoshi Yamada et al. BONE
- EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition
- (2013) Qing Gao et al. HUMAN PATHOLOGY
- Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
- (2013) M. Nishimura et al. Cancer Discovery
- Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
- (2012) Ruth Holm et al. International Journal of Medical Sciences
- Eph Receptors and Ephrin Signaling Pathways: A Role in Bone Homeostasis
- (2012) Claire M. Edwards et al. International Journal of Medical Sciences
- Suppression of EphB4 improves the inhibitory effect of mTOR shRNA on the biological behaviors of ovarian cancer cells by down-regulating Akt phosphorylation
- (2012) Xiangyi Ma et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer
- (2011) William M. Merritt et al. CANCER BIOLOGY & THERAPY
- EphrinA1 stimulates cell attachment and inhibits cell aggregation through the EphA receptor pathway in human endometrial carcinoma-derived Ishikawa cells
- (2011) H. Fujii et al. HUMAN REPRODUCTION
- EphA2 overexpression promotes ovarian cancer growth
- (2010) Chunhua Lu et al. CANCER BIOLOGY & THERAPY
- EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma
- (2010) J. W. Lee et al. CLINICAL CANCER RESEARCH
- Ephrin A1 induces intercellular dissociation in Ishikawa cells: possible implication of the Eph-ephrin A system in human embryo implantation
- (2010) H. Fujii et al. HUMAN REPRODUCTION
- Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism
- (2010) Nao Hiramoto-Yamaki et al. JOURNAL OF CELL BIOLOGY
- EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer
- (2009) Aparna A. Kamat et al. CANCER
- Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers
- (2009) Syed Mahfuzul Alam et al. GYNECOLOGIC ONCOLOGY
- Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
- (2008) S M Alam et al. BRITISH JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started